Bookmark and Share

ACE INHIBITORS Drug Information Page

Updated 08/09/2010 12:50:37 AM

ProductSourceDateLinkData
ACE INHIBITORSMHRA2009-5-5ACE INHIBITORS-MHRA-2009-5-5MHRA has issued drug updates: Aliskiren: risk of angioedema and renal dysfunction ACE inhibitors and angiotensin II receptor antagonists: recommendations on use during breastfeeding Non-steroidal anti-inflammatory drugs: reminder on renal failure and impairment Orlistat: key safety information to support pharmacy availability New advice on oral salicylate gels for those younger than age 16 years Fortodol: risk of serious liver damage
ACE INHIBITORSMHRA2007-12-3ACE INHIBITORS-MHRA-2007-12-3MHRA has issued drug updates: Recombinant human erythropoietins: new prescribing advice Rosiglitazone and pioglitazone: cardiovascular safety Dosulepin: measures to reduce risk of fatal overdose ACE inhibitors and angiotensin II receptor antagonists: not for use in pregnancy Short-acting � agonists: myocardial ischaemia Varenicline: possible effects on driving, and psychiatric illness* NSAIDs and coxibs: balancing of cardiovascular and gastrointestinal risks Aprotinin: suspension of Marketing Authorisations Lumiracoxib: suspension of Marketing Authorisations Strontium ranelate: risk of severe allergic reactions Talc for pleurodesis: risk of adverse events

Joining this website will allow you to recieve emails about any pharmaceutial you are interested in or you can search for other pharmaceuticals on this website. Joining should only take 2 minutes.



Image of checkdrugs.com Logo
© Cardan Technologies Inc

This site is presented as an educational source only and you use it at your own risk. The information on this site is not a substitute for a visit with your doctor or pharmacist. Always talk to your doctor before changing medications or dosage, or if you experience any serious side effects.